Arvin Capital Management LP Increases Stake in Danaher Co. (NYSE:DHR)

Arvin Capital Management LP raised its stake in Danaher Co. (NYSE:DHR - Free Report) by 34.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 42,001 shares of the conglomerate's stock after acquiring an additional 10,831 shares during the quarter. Danaher makes up approximately 2.7% of Arvin Capital Management LP's investment portfolio, making the stock its 15th largest position. Arvin Capital Management LP's holdings in Danaher were worth $9,641,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the fourth quarter worth about $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter worth about $31,000. Golden State Wealth Management LLC purchased a new position in Danaher during the fourth quarter worth approximately $31,000. Hurley Capital LLC acquired a new stake in Danaher in the fourth quarter valued at approximately $34,000. Finally, Pineridge Advisors LLC increased its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 11.10% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on DHR shares. The Goldman Sachs Group dropped their price target on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research note on Wednesday. JPMorgan Chase & Co. cut their target price on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Royal Bank of Canada reiterated an "outperform" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday. Finally, Robert W. Baird decreased their target price on Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research report on Wednesday. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and a consensus price target of $264.40.

Danaher Trading Up 0.4 %

Shares of DHR stock traded up $0.87 during trading on Friday, hitting $197.37. 2,608,666 shares of the stock traded hands, compared to its average volume of 3,352,400. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The firm has a market capitalization of $141.06 billion, a P/E ratio of 37.38, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The firm's fifty day moving average price is $200.87 and its 200-day moving average price is $224.58. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. As a group, research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 25th. Shareholders of record on Friday, March 28th were given a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, March 28th. This is a boost from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's dividend payout ratio (DPR) is currently 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.